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Abstract 1 
Objective: Infectious complications including sepsis that often occur after 2 
liver transplantation (LT) comprise the most frequent causes of in-hospital 3 
death. This study investigated predictors of posttransplant infectious 4 
complications to establish a strategy with which to improve short-term 5 
outcomes after LT. 6 
Methods: We used univariate and multivariate analyses to assess pre- and 7 
perioperative risk factors for posttransplant infectious complications among 8 
100 consecutive patients who underwent living donor LT between February 9 
2008 and February 2010 at our institute. 10 
Results: Multivariate analysis showed that low preoperative body cell mass 11 
(BCM) and of the absence of preoperative supplementation with 12 
branched-chain amino acids were of prognostic significance for 13 
posttransplant sepsis. In addition, Child-Pugh classification C and massive 14 
operative blood loss were independent risk factors for posttransplant 15 
bacteremia and preoperative low BCM was an independent risk factor for 16 
in-hospital death due to infection. 17 
Conclusion: Pretransplant nutritional intervention as well as a reduction in 18 
operative blood loss would help to prevent posttransplant infectious 19 
complications developing during living donor LT. BCAA supplementation 20 
before LT affects the occurrence of infectious complications. 21 
22 
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Introduction 1 
 Infections after liver transplantation (LT) are the most frequent causes of 2 
morbidity and in-hospital death [1]. Patients who undergo LT are 3 
essentially regarded as being at unusually high risk for perioperative 4 
infection. For example, protein-energy malnutrition, which is common in 5 
patients with end-stage liver disease requiring LT, is considered to confer 6 
vulnerability to preoperative infection including spontaneous bacterial 7 
peritonitis and pneumonia via deteriorated immune function [2,3]. Liver 8 
transplantation itself is a massive invasion of the host. The number of 9 
intraoperatively transfused cellular blood products is also a risk factor for 10 
infections [4]. Furthermore, immunosuppression as well as multiple 11 
catheter insertion increases the risk of posttransplant infection. 12 
Consequently, infectious complications including sepsis and bacteremia 13 
often occur after LT and are the most frequent causes of in-hospital death. 14 
Therefore, the prevention of posttransplant infection plays a crucial role in 15 
improving short-term outcomes after LT. 16 
 Malnutrition is a risk factor for postoperative complications and mortality 17 
rates in patients with a cirrhotic liver who undergo surgery [5,6]. However, 18 
the impact of preoperative nutritional status as well as of nutritional 19 
intervention on postoperative infectious complications in LT remains 20 
controversial [7-10], especially in patients undergoing living donor LT 21 
(LDLT). Patients with advanced cirrhosis characteristically show a decrease 22 
   
 6 
in plasma concentrations of branched-chain amino acids (BCAAs). These 1 
BCAAs serve not only as an essential substrate in the synthesis of body 2 
proteins, but also act as an important regulator of protein turnover. 3 
Moreover, BCAAs have beneficial effects on hepatic encephalopathy 4 
through the promotion of ammonia detoxification and the correction of 5 
plasma amino acid imbalance, liver regeneration, and hepatic cachexia in 6 
patients with liver diseases [11]. Improving systemic conditions, including 7 
nutritional status, to the greatest extent possible before LT facilitates early 8 
postoperative recovery. Supplementation with a BCAA-enriched nutrient 9 
mixture is reportedly beneficial not only for patients with liver cirrhosis, 10 
but also for patients undergoing hepatectomy [12-15]. However, the value 11 
of pretransplant BCAA supplementation remains unclear. The aim of the 12 
present study was therefore to examine pre- and perioperative predictors 13 
including nutritional factors such as BCAA supplementation for 14 
posttransplant infectious complications so that a strategy can be established 15 
to improve short-term outcomes after LDLT. 16 
 17 
Methods 18 
 The present report retrospectively analyzed data from 100 consecutive 19 
adult patients (46 males and 54 females) aged ≥18 (range, 18 – 69; median, 20 
56) years who underwent LDLT at Kyoto University Hospital between 21 
February 2008 and February 2010 after introducing the nutritional 22 
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assessment described below. The Model for End-stage Liver Disease 1 
(MELD) score was 19 (range, 7 – 46), 32 patients were ABO incompatible 2 
and 68 were identical or compatible. The indications for LT were 3 
hepatocellular carcinoma (n = 33), followed by hepatocellular diseases 4 
such as hepatitis B or C virus-associated liver cirrhosis (n = 19), 5 
progressive intrahepatic cholestatic diseases including primary biliary 6 
cirrhosis and primary sclerosing cholangitis (n = 13), fulminant hepatic 7 
failure (n = 11) and other causes (n = 24). The patients provided written 8 
informed consent before the start of the study, which was approved by the 9 
Ethics Committee of Kyoto University and conducted in accordance with 10 
the Declaration of Helsinki of 1975 as revised in 1996. 11 
 We introduced body composition analysis using multifrequency 12 
bioelectrical impedance with eight tactile electrodes (InBody 720; Biospace, 13 
Tokyo, Japan) in February 2008 for patients undergoing LT. Patients fast 14 
for at least 3 hours and void immediately before starting the analysis. 15 
Various parameters are automatically measured, including body mass index, 16 
intra- and extracellular water, body fat mass, protein, and body cell mass 17 
(BCM), which is the sum of intracellular fluid and protein and a reliable 18 
parameter of nutritional status. The BCM is automatically calculated by the 19 
InBody 720 for each patient and displayed as a normal range (e.g. 23.0 ~ 20 
28.1 kg). Low and high BCM values are below the lower limit and above 21 
the upper limit, respectively. Ten patients who could not undergo 22 
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preoperative InBody 720 examination due to undergoing emergency 1 
surgery were excluded from the BCM analysis. 2 
 Preoperative nutritional therapy was administered for about 2 weeks 3 
before LDLT at the discretion of the surgeon or attending physician after 4 
admission to our department. The therapy consisted of a nutrient mixture 5 
enriched with branched-chain amino acids (BCAA; Aminoleban EN; 6 
Otsuka Pharmaceutical Co., Tokyo, Japan), BCAA nutrients (Livact; 7 
Ajinomoto Pharma Co., Tokyo, Japan) or none. Thirty-seven of the patients 8 
received the preoperative BCAA-enriched nutrient mixture (100 g/day), 28 9 
received BCAA nutrients (12.45 g/day), and 35 received no nutritional 10 
therapy. Dieticians adjusted the type and amount of food for each patient to 11 
maintain a total caloric intake of 35 - 40 kcal/kg and a protein intake of 1.2 12 
to 1.5 g/kg including BCAA nutrients according to the guidelines of the 13 
European Society of Parenteral and Enteral Nutrition. 14 
 The selection criteria for the recipients as well as surgical techniques for 15 
recipient operations have been described in detail elsewhere [16-18]. 16 
Immunosuppressive therapy usually consisted of tacrolimus or 17 
cyclosporine and low-dose steroids as described elsewhere [18,19]. 18 
 We examined preoperative risk factors (including preoperative 19 
nutritional parameters) for posttransplant sepsis, posttransplant bacteremia 20 
and in-hospital death due to infection. Data regarding the following 21 
recipient variables for each patient were analyzed: age of recipient, gender, 22 
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original disease underlying the need for LT, ABO compatibility, Child-Pugh 1 
classification, MELD score, graft type (right or left lobe), graft-recipient 2 
weight ratio (GRWR), operative duration, operative blood loss, 3 
pretransplant BCM, and preoperative nutritional therapy. We defined 4 
conditions fulfilling the diagnostic criteria for systemic inflammatory 5 
response syndrome with infections including blood, urine and pulmonary 6 
infection as sepsis [20]. Infections were defined using the criteria proposed 7 
by the Centers for Disease Control and based on reports regarding liver 8 
transplant patients [21]. Isolation of bacteria other than common skin 9 
contaminants from a single blood culture in the presence of clinical 10 
symptoms or of infection was considered bacteremia. When caused by 11 
common skin contaminants, bacteremia was considered significant only if 12 
an organism was isolated from two blood cultures and clinical signs of 13 
infection were evident. 14 
 15 
Statistical analysis 16 
Categorical variables were compared using the χ2 test or Fisher’s exact test 17 
where appropriate. Any variable identified as significant (P < 0.05) or with 18 
P < 0.10 in univariate analyses using the above tests was considered a 19 
candidate for multivariate analysis using multiple logistic regression 20 
models. A P value of < 0.05 was considered significant. All data were 21 
statistically analyzed using JMP 5.0.1 software. 22 




Posttransplant sepsis 3 
Univariate analysis showed that age <60 years, MELD score ≥20, low 4 
pretransplant BCM and the absence of preoperative supplementation with 5 
the BCAA-enriched nutrient mixture were of prognostic significance for 6 
posttransplant sepsis (Table 1). Multivariate analysis revealed that low 7 
pretransplant BCM (p = 0.032) and no preoperative BCAA-enriched 8 
nutrient supplementation (p = 0.020) were of independent prognostic 9 
significance for posttransplant sepsis (Table 2). 10 
 11 
Bacteremia 12 
Age <60 years, Child-Pugh classification C, perioperative blood loss ≥10 L 13 
and no preoperative BCAA-enriched supplementation were risk factors for 14 
bacteremia (Table 3). Multivariate analysis revealed that Child-Pugh 15 
classification C (p = 0.002) and perioperative blood loss ≥10 L (p = 0.018) 16 
were independent risk factors for posttransplant bacteremia (Table 4). 17 
 18 
In-hospital death due to infection 19 
Age <60 years, Child-Pugh classification C and low preoperative BCM 20 
were significant risk factors for in-hospital death due to infection (Table 5). 21 
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Multivariate analysis showed that only low preoperative BCM (p = 0.004) 1 
was an independent risk factor (Table 6). 2 
 3 
Discussion 4 
 The present study examined risk factors affecting three types of infectious 5 
complications after LDLT. We identified the independent risk factors as 6 
Child-Pugh classification C, massive perioperative blood loss, low 7 
pretransplant BCM and the absence of preoperative supplementation with a 8 
BCAA-enriched nutrient mixture. Decompensated liver cirrhosis indicated 9 
by Child-Pugh classification C is usually accompanied by deteriorated 10 
immune function and nutritional status at the time of LT. Child-Pugh 11 
classification C was thus undoubtedly a risk factor of postoperative 12 
infection, which is in line with the results of our recent report [22]. Massive 13 
perioperative bleeding is an established factor for postoperative 14 
complications of digestive surgery as well as LT and massive blood loss is 15 
usually associated with massive blood transfusion. Homologous blood 16 
transfusion has adverse effects such as a risk of infection and 17 
graft-versus-host disease. This detrimental effect is supposed to be caused 18 
by nonspecific immunosuppression such as decreased CD4/CD8 ratios 19 
[23,24] and natural killer cell activity [25,26]. We recently reported that 20 
low pretransplant BCM and the absence of preoperative BCAA-enriched 21 
supplementation are closely associated with postoperative sepsis [27]. The 22 
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present findings supported not only our previous results but also 1 
demonstrated the powerful impact of pretransplant nutritional conditions 2 
and preoperative treatment with BCAA-enriched nutrient mixture on 3 
infectious complications. 4 
 The reason for the beneficial effects of pretransplant BCAA 5 
supplementation, however, remains unclear. One possible explanation is 6 
improvement in pretransplant nutritional status. Some nutritional 7 
parameters, such as prealbumin, total lymphocyte count, and 8 
BCAA/tyrosine ratio, were significantly improved by pretransplant 9 
nutritional intervention including BCAA-enriched nutrient mixture (in 10 
submission). Another possible reason is the improvement of the immune 11 
system. Bassit et al. reported that BCAA supplementation improves the 12 
ability of peripheral blood mononuclear cells to proliferate in response to 13 
mitogens after long distance intense exercise [28]. Lorenzo et al. reported 14 
that septic patients receiving a high-BCAA preparation showed decreased 15 
mortality and improved nutritional parameters [29]. In patients with 16 
advanced liver cirrhosis, Kakazu et al. showed that elevating extracellular 17 
concentration of BCAAs ex vivo improved the function of myeloid 18 
dendritic cells [30]. Our results suggest that preoperative BCAA-enriched 19 
supplementation can help to prevent postoperative sepsis through 20 
nutritional and immune improvement, although a randomized controlled 21 
study is required to confirm this hypothesis. Taken together with our 22 
   
 13 
findings demonstrating that the absence of posttransplant enteral nutrition 1 
is a risk factor affecting in-hospital mortality after LT [1], perioperative 2 
nutritional treatment represents a promising strategy for improving 3 
short-term outcomes after LT. 4 
 Based on the current findings, we considered establishing an 5 
interventional strategy against these risk factors to prevent posttransplant 6 
infectious complications. Child-Pugh classification C itself is an indication 7 
for LT. In contrast, massive blood loss, pretransplant low BCM and the 8 
absence of preoperative BCAA-enriched supplementation are factors that 9 
can be altered to some extent. Blood loss can be reduced by more careful 10 
surgical maneuvering and the frequent application of hemostatic devices 11 
during dissection of the liver from surrounding ligaments and the inferior 12 
vena cava. The sum of intracellular fluid and body protein, BCM, is 13 
considered a highly reliable parameter of nutritional status. Especially for 14 
patients undergoing LT who usually have abundant extracellular fluid such 15 
as edema and ascites, BCM can assess their nutritional status more 16 
accurately than other nutritional parameters including body mass index and 17 
lean body mass. Low BCM in patients with cirrhosis suggests a decrease in 18 
skeletal muscle volume, which could interfere with early postoperative 19 
mobilization and result in pulmonary complications including aspiration 20 
pneumonia and atelectasis. Therefore, we have recently introduced a 21 
pretransplant rehabilitation program to encourage early postoperative 22 
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mobilization and avert pulmonary dysfunction. Since LDLT is an elective 1 
procedure that differs from deceased donor LT, a pretransplant 2 
rehabilitation program can be implemented until the day of transplant. 3 
 The prevalence of metabolic disorders including metabolic syndrome 4 
on liver–transplant population has recently attracted attention [31-33]. 5 
The prevalence of metabolic syndrome in post-LT patients is 6 
significantly higher than that estimated in the general population and 7 
metabolic syndrome is associated with an increased risk of major 8 
vascular events and long-term fibrosis progression. Therefore, 9 
prevention of post-LT metabolic syndrome would also be a crucial 10 
objective of perioperative nutritional treatment. 11 
 Supplementation with a BCAA-enriched nutrient mixture is reportedly 12 
beneficial not only for patients with liver cirrhosis but also for patients 13 
undergoing hepatectomy [23-26]. However, the value of pretransplant 14 
BCAA supplementation has remained unclear. Our results suggest that 15 
preoperative BCAA-enriched supplementation can help to prevent 16 
postoperative sepsis, although a randomized controlled study is required to 17 
confirm this notion. Taken together with our findings demonstrating that 18 
the absence of posttransplant enteral nutrition is a risk factor affecting 19 
in-hospital mortality after LT [1], perioperative nutritional treatment should 20 
be a promising strategy to improve short-term outcomes after LT. 21 
 22 
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Conclusion 1 
 Preoperative nutritional status, supplementation with a nutrient mixture 2 
enriched with BCAAs and massive operative blood loss were closely 3 
associated with the occurrence of posttransplant infectious complications. 4 
Perioperative management including nutritional therapy is needed to 5 
improve short-term outcomes after LT. 6 
 7 
8 
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